Thalidomide for erythema nodosum leprosum and other applications.

@article{Okafor2003ThalidomideFE,
  title={Thalidomide for erythema nodosum leprosum and other applications.},
  author={Mark C Okafor},
  journal={Pharmacotherapy},
  year={2003},
  volume={23 4},
  pages={481-93}
}
Thalidomide, administered as a sedative and antiemetic decades ago, was considered responsible for numerous devastating cases of birth defects and consequently was banned from markets worldwide. However, the drug remarkably has resurfaced with promise of immunomodulatory benefit in a wide array of immunologic disorders for which available treatments were limited. It is approved by the Food and Drug Administration for erythema nodosum leprosum (ENL). Although the relative paucity of leprosy and… CONTINUE READING